THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Manu Pandey to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Manu Pandey has written about Antibodies, Monoclonal, Humanized.
Manu Pandey
Connection Strength
0.161
Antibodies, Monoclonal, Humanized
  1. Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity. Clin Cancer Res. 2021 01 01; 27(1):87-95.
    View in: PubMed
    Score: 0.161
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES